# An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

> **NCT07438405** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Amgen** · enrollment: 30 (estimated)

## Conditions studied

- Thyroid Eye Disease

## Interventions

- **DRUG:** AMG 732

## Key facts

- **NCT ID:** NCT07438405
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2028-01-29
- **Final completion:** 2028-07-14
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07438405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07438405, "An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07438405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*